Geron (GERN) Reaches $2.04 After 9.00% Up Move; Last Week Marsh & McLennan Companies, Inc. (MMC) Coverage

January 14, 2018 - By Stephen Andrade

Among 15 analysts covering Marsh & McLennan (NYSE:MMC), 8 have Buy rating, 0 Sell and 7 Hold. Therefore 53% are positive. Marsh & McLennan had 33 analyst reports since September 8, 2015 according to SRatingsIntel. Keefe Bruyette & Woods maintained the shares of MMC in report on Thursday, August 17 with “Buy” rating. Keefe Bruyette & Woods maintained Marsh & McLennan Companies, Inc. (NYSE:MMC) on Thursday, December 21 with “Buy” rating. On Tuesday, August 8 the stock rating was maintained by Wells Fargo with “Buy”. As per Wednesday, October 4, the company rating was downgraded by Deutsche Bank. The stock has “Neutral” rating by Credit Suisse on Monday, January 11. RBC Capital Markets maintained the stock with “Buy” rating in Friday, December 8 report. The stock of Marsh & McLennan Companies, Inc. (NYSE:MMC) has “Buy” rating given on Thursday, July 13 by Citigroup. Keefe Bruyette & Woods maintained it with “Buy” rating and $92.0 target in Monday, December 4 report. RBC Capital Markets maintained the stock with “Outperform” rating in Friday, February 5 report. The company was upgraded on Wednesday, January 13 by Keefe Bruyette & Woods. See Marsh & McLennan Companies, Inc. (NYSE:MMC) latest ratings:

21/12/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $94.0 Maintain
08/12/2017 Broker: RBC Capital Markets Rating: Buy New Target: $93.0 Maintain
04/12/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $92.0 Maintain
06/12/2017 Broker: UBS Old Rating: Buy New Rating: Neutral Downgrade
04/12/2017 Broker: Goldman Sachs Rating: Neutral New Target: $88 Initiates Coverage On
27/10/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $88.0 Maintain
16/10/2017 Broker: Barclays Capital Rating: Overweight Old Target: $92 New Target: $93 Maintain
13/10/2017 Broker: Jefferies Rating: Hold New Target: $87.0 Maintain
04/10/2017 Broker: Deutsche Bank Old Rating: Buy New Rating: Hold Downgrade
02/10/2017 Broker: RBC Capital Markets Rating: Buy New Target: $85.0 Maintain




The stock of Geron Corporation (NASDAQ:GERN) is a huge mover today! The stock increased 5.15% or $0.1 during the last trading session, reaching $2.04. About 2.41M shares traded or 55.75% up from the average. Geron Corporation (NASDAQ:GERN) has risen 13.81% since January 14, 2017 and is uptrending. It has underperformed by 2.89% the S&P500.The move comes after 8 months positive chart setup for the $324.83M company. It was reported on Jan, 14 by Barchart.com. We have $2.22 PT which if reached, will make NASDAQ:GERN worth $29.23 million more.

Investors sentiment decreased to 0.95 in Q3 2017. Its down 0.02, from 0.97 in 2017Q2. It worsened, as 56 investors sold Marsh & McLennan Companies, Inc. shares while 215 reduced holdings. 61 funds opened positions while 196 raised stakes. 425.59 million shares or 1.13% more from 420.82 million shares in 2017Q2 were reported. Picton Mahoney Asset Mgmt holds 0.03% of its portfolio in Marsh & McLennan Companies, Inc. (NYSE:MMC) for 4,800 shares. Obermeyer Wood Inv Counsel Lllp owns 3,250 shares. Boston Family Office Ltd accumulated 179,839 shares. Liberty Mutual Asset owns 23,053 shares for 0.11% of their portfolio. Gamco Invsts Et Al accumulated 4,145 shares. 1.55M were accumulated by Glenmede Na. Putnam Fl accumulated 1.76% or 219,735 shares. 6,000 were reported by Cypress. First Personal Services holds 0.07% or 3,745 shares in its portfolio. Diamond Hill Inc invested in 2.58 million shares or 1.14% of the stock. Jfs Wealth Ltd Co accumulated 0.05% or 2,259 shares. Panagora Asset Management Incorporated holds 0.01% in Marsh & McLennan Companies, Inc. (NYSE:MMC) or 20,413 shares. Coho Prtn has invested 4.5% in Marsh & McLennan Companies, Inc. (NYSE:MMC). Blackrock Incorporated holds 0.17% or 39.97 million shares. Dsm Capital Partners Limited Co accumulated 4,350 shares.

The stock increased 0.89% or $0.72 during the last trading session, reaching $81.74. About 2.72M shares traded or 49.40% up from the average. Marsh & McLennan Companies, Inc. (NYSE:MMC) has risen 16.25% since January 14, 2017 and is uptrending. It has underperformed by 0.45% the S&P500.

Since August 21, 2017, it had 0 buys, and 2 sales for $53.53 million activity. 618,557 shares valued at $51.21M were sold by Glaser Daniel S on Monday, December 18. Shares for $2.32 million were sold by Gilbert E Scott.

Marsh & McLennan Companies, Inc., a professional services firm, provides advice and solutions in the areas of risk, strategy, and people worldwide. The company has market cap of $41.72 billion. It operates through two divisions, Risk and Insurance Services; and Consulting. It has a 22.39 P/E ratio. The Risk and Insurance Services segment offers risk management services, such as risk advice, risk transfer, risk control, and mitigation solutions, as well as insurance, reinsurance broking, catastrophe and financial modeling services, and related advisory services.

Analysts await Geron Corporation (NASDAQ:GERN) to report earnings on March, 7. They expect $-0.04 EPS, up 20.00% or $0.01 from last year’s $-0.05 per share. After $-0.04 actual EPS reported by Geron Corporation for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Geron Corporation operates as a biopharmaceutical company. The company has market cap of $324.83 million. The firm supports the clinical stage development of a telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. It currently has negative earnings. It has collaboration and license agreement with Janssen Biotech, Inc. to develop and commercialize imetelstat worldwide for indications in oncology, including hematologic myeloid malignancies and other human therapeutic uses.

Investors sentiment decreased to 0.97 in 2017 Q3. Its down 0.24, from 1.21 in 2017Q2. It dropped, as 10 investors sold Geron Corporation shares while 27 reduced holdings. 11 funds opened positions while 25 raised stakes. 61.75 million shares or 0.63% more from 61.36 million shares in 2017Q2 were reported. Millennium Mngmt Ltd holds 0% in Geron Corporation (NASDAQ:GERN) or 15,116 shares. Tiaa Cref Investment Mngmt Ltd Liability Corp reported 0% of its portfolio in Geron Corporation (NASDAQ:GERN). Metropolitan Life Insur Com New York has 97,180 shares for 0% of their portfolio. Voya Inv Ltd Com stated it has 0% in Geron Corporation (NASDAQ:GERN). 37,900 are held by Art Ltd. Raymond James Advsrs Inc invested in 0% or 82,426 shares. Principal Financial Group invested in 23,069 shares or 0% of the stock. State Board Of Administration Of Florida Retirement Systems owns 0% invested in Geron Corporation (NASDAQ:GERN) for 138,882 shares. Great West Life Assurance Can reported 0% stake. Price T Rowe Associate Inc Md holds 109,400 shares. State Street holds 0% or 5.09M shares in its portfolio. Glenmede Trust Na reported 0% stake. Vanguard Group has 7.45M shares. Aperio Group Inc Lc, California-based fund reported 17,744 shares. Geode Capital Mngmt Ltd Liability invested in 0% or 1.32 million shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: